Dean NM - Search Results

1

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

Derenne S, Monia B, Dean NM, Taylor JK, Rapp MJ, Harousseau JL, Bataille R, Amiot M. Derenne S, et al. Among authors: dean nm. Blood. 2002 Jul 1;100(1):194-9. doi: 10.1182/blood.v100.1.194. Blood. 2002. PMID: 12070027 Free article.

2

Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli.

Taylor JK, Zhang QQ, Monia BP, Marcusson EG, Dean NM. Taylor JK, et al. Among authors: dean nm. Oncogene. 1999 Aug 5;18(31):4495-504. doi: 10.1038/sj.onc.1202836. Oncogene. 1999. PMID: 10442640

3

Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.

Taylor JK, Zhang QQ, Wyatt JR, Dean NM. Taylor JK, et al. Among authors: dean nm. Nat Biotechnol. 1999 Nov;17(11):1097-100. doi: 10.1038/15079. Nat Biotechnol. 1999. PMID: 10545916

4

Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs.

Broome HE, Yu AL, Diccianni M, Camitta BM, Monia BP, Dean NM. Broome HE, et al. Among authors: dean nm. Leuk Res. 2002 Mar;26(3):311-6. doi: 10.1016/s0145-2126(01)00118-7. Leuk Res. 2002. PMID: 11792421

5

Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype.

Pan B, Yao KS, Monia BP, Dean NM, McKay RA, Hamilton TC, O'Dwyer PJ. Pan B, et al. Among authors: dean nm. Biochem Pharmacol. 2002 May 1;63(9):1699-707. doi: 10.1016/s0006-2952(02)00841-9. Biochem Pharmacol. 2002. PMID: 12007573

6

Pharmacology of antisense oligonucleotide inhibitors of protein expression.

Cooper SR, Taylor JK, Miraglia LJ, Dean NM. Cooper SR, et al. Among authors: dean nm. Pharmacol Ther. 1999 May-Jun;82(2-3):427-35. doi: 10.1016/s0163-7258(99)00002-9. Pharmacol Ther. 1999. PMID: 10454217 Review.

7

Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.

Karras JG, McKay RA, Dean NM, Monia BP. Karras JG, et al. Among authors: dean nm. Mol Pharmacol. 2000 Aug;58(2):380-7. doi: 10.1124/mol.58.2.380. Mol Pharmacol. 2000. PMID: 10908306

8

Antisense inhibition of membrane-bound human interleukin-5 receptor-alpha chain does not affect soluble receptor expression and induces apoptosis in TF-1 cells.

Karras JG, McKay RA, Lu T, Dean NM, Monia BP. Karras JG, et al. Among authors: dean nm. Antisense Nucleic Acid Drug Dev. 2000 Oct;10(5):347-57. doi: 10.1089/oli.1.2000.10.347. Antisense Nucleic Acid Drug Dev. 2000. PMID: 11079574

9

In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID/NOD-Hu model.

Fennell DA, Corbo MV, Dean NM, Monia BP, Cotter FE. Fennell DA, et al. Among authors: dean nm. Br J Haematol. 2001 Mar;112(3):706-13. doi: 10.1046/j.1365-2141.2001.02603.x. Br J Haematol. 2001. PMID: 11260076 Free article.

10

Regulation of pre-mRNA splicing by antisense oligonucleotides.

Taylor JK, Dean NM. Taylor JK, et al. Among authors: dean nm. Curr Opin Drug Discov Devel. 1999 Mar;2(2):147-51. Curr Opin Drug Discov Devel. 1999. PMID: 19649941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters